Biotechnology

11 February 2025   Key ruling in favour of Kansas-based biotech on genetically engineered proteins from China | Court supports ITC position | Small market segments can be substantial enough for domestic industry requirement.

Latest Features

Americas
Will this year be defined by a concerted shift towards ‘One Health’? Simon Kiddle and Rebecca Tollervey of Mewburn Ellis explore.
Americas
Key developments for the industry this year include a more pro-patent administration and USPTO changes, say Carla Ji-Eun Kim and Deborah Sterling of Sterne Kessler.
Americas
Key similarities and differences between the patent systems, particularly in biotech, offer lessons and opportunities for rightsholders, say Daniela Fasoli of Simões Propriedade Intelectual and Jeffrey Morton of Haynes and Boone.
Asia
Free trade zones in Beijing, Shanghai, Guangdong, and Hainan are designed to attract capital into China’s fast-growing healthcare sectors, says Li Mi of Lusheng.
Americas
Well-drafted contracts and ironclad tech security can save time and money when an ex-employee steals IP ‘like sugar packets in Starbucks’, finds Tom Phillips.
Biotechnology
The shift towards preventative pharmaceuticals could open new, and highly valuable, markets but it must be strengthened by patent rights, says Sam Andrews, senior paralegal at Powell Gilbert.
Biotechnology
AI has the potential to revolutionise patent examination but uneven adoption of the technology could undermine fairness in the system, says Matthew Veale of Patsnap.
Biotechnology
As artificial intelligence creates a complex legal landscape for healthcare and medtech, Janine Swarbrick of HGF explores two case studies that shed light on how to claim an AI invention.
All features


More News

9 January 2025   Skilled in microbiome, medical devices and next generation diagnostics, the new partner is skilled in creating IP strategies for startups, spinouts and SMEs.
7 January 2025   Case concerns allegations that ex-senior vice president of business development at Skye Orthobiologics misappropriated secrets and breached contract | Companies in dispute process and manufacture medical products derived from human placental tissue.
7 January 2025   Biotech walks away with another win as Fed Circ upholds PTAB decision | Labcorp’s attempt to overturn $373m verdict fails | Court finds Ravgen’s method for preserving DNA in blood samples not obvious.
24 December 2024   Massachusetts medical research company is awarded damages following a jury verdict that found a Japanese pharma had infringed on its patent | Patent relates to Duchenne muscular dystrophy treatment.
16 December 2024   A Delaware jury unanimously sided with Sanofi-owned biotech Inhibrx, clearing it of trade secrets misappropriation claims. Amy Candido of Wilson Sonsini shares insights into the defence strategy that led to the win.
12 December 2024   Firm expands its Mechanical & Electromechanical Technologies Practice with latest addition | Partner brings nearly two decades of experience in IP strategy, litigation, and transactions | Experience in biotechnology, medical devices, and blockchain.
10 December 2024   BlueAllele “plausibly alleged” that some of Intellia’s uses of technology were not reasonably related to FDA approval | Biotech claimed competitor received over $100m from Regeneron for using innovation to research therapeutic candidates.
More news